There is limited data outside of clinical trials on health utility scores (HUS) in metastatic lung cancer patients. This longitudinal cohort study evaluated EQ5D-3L-derived HUS in 475 outpatients. Mean scores were higher in patients carrying driver mutations stable on targeted treatments, than in patients without alterations stable on chemotherapy. Such differences should be considered in economic analyses of upcoming treatments.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iQDtoc
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
An examination of the etiologic overlap between the genetic and environmental influences on insomnia and common psychopathology. Depre...
-
is the premiere name in online OSHA Outreach training and safety courses. Our interactive courses include 10 hour and 30 hour OSHA Outreach,...
-
Masters Thesis Proposal Outline INTRODUCTION (1 PAGE) • What is the general topic area • Why this topic is relevant/important (how important...
-
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Me...
-
Abstract Background The introduction of aggressive chemo-radiotherapy regimens has improved overall survival in children with primitive ...
-
6 Top Reference Sites to Write a Winning Research Paper . Tina 6 Top Reference Sites to Write a Winning Research Paper. There may be guideli...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nGJfK4 via IFTTT
-
Abstract Purpose of Review Recent evidence suggests that the developmental signaling pathways—Wnt, Notch, and Hedgehog—are critically in...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου